Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Clinical trial NCT00516412 · COMPLETED
Trial details
- NCT number
- NCT00516412
- Sponsor
- Swiss Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2010-01-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.